- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears Bennett M-DSI system
Bennett X-Ray has joined the ranksof vendors offering digital spot mammography devices. The Foodand Drug Administration last week issued 510(k) marketing clearanceto Bennett's M-DSI product, and Bennett is ready to begin shippingthe device, according to
Bennett X-Ray has joined the ranksof vendors offering digital spot mammography devices. The Foodand Drug Administration last week issued 510(k) marketing clearanceto Bennett's M-DSI product, and Bennett is ready to begin shippingthe device, according to director of sales and marketing GradyMiars.
M-DSI retrofits to Bennett's Contour mammography system andis based on a charge-coupled device (CCD) camera and fiber-opticcoupling technology (SCAN 6/15/94). It was developed by Copiague,NY-based Bennett in coordination with aerospace firm NorthropGrumman.
M-DSI will compete with digital spot mammography products fromLorad and Fischer Imaging. In addition, all three vendors planto highlight their work in full-breast digital imaging at theupcoming Radiological Society of North America meeting.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
